Publications by authors named "Justin Huard"

Claim this Profile
N
NL-201 Upregulates MHC-I Expression and Intratumoral T-cell Receptor Diversity, and Demonstrates Robust Antitumor Activity as Monotherapy and in Combination with PD-1 Blockade.
Christie Mortales, Benjamin Dutzar, Jerry Chen, Alex Chen, Justin Huard

Cancer Immunol Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling mouse brown and white adipocytes to identify metabolically relevant small ORFs and functional microproteins.
Thomas F Martinez, Sally Lyons-Abbott, Angie L Bookout, Eduardo V De Souza, Cynthia Donaldson, Justin Huard

Cell Metab· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altering Antibody-Drug Conjugate Binding to the Neonatal Fc Receptor Impacts Efficacy and Tolerability.
Kevin J Hamblett, Tiep Le, Brooke M Rock, Dan A Rock, Sophia Siu, Justin N Huard

Mol Pharm· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FLT3 and CDK4/6 inhibitors: signaling mechanisms and tumor burden in subcutaneous and orthotopic mouse models of acute myeloid leukemia.
Yaping Zhang, Cheng-Pang Hsu, Jian-Feng Lu, Mita Kuchimanchi, Yu-Nien Sun, Justin Huard

J Pharmacokinet Pharmacodyn· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of AMG 925, a FLT3/CDK4 dual kinase inhibitor for treating acute myeloid leukemia.
Kathleen Keegan, Cong Li, Zhihong Li, Ji Ma, Mark Ragains, Justin Huard

Mol Cancer Ther· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of AMG 925, a FLT3 and CDK4 dual kinase inhibitor with preferential affinity for the activated state of FLT3.
Zhihong Li, Xianghong Wang, John Eksterowicz, Michael W Gribble, Grace Q Alba, Justin N Huard

J Med Chem· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conatumumab, a fully human agonist antibody to death receptor 5, induces apoptosis via caspase activation in multiple tumor types.
Paula J Kaplan-Lefko, Jonathan D Graves, Stephen J Zoog, Yang Pan, Jason Wall, Justin N Huard

Cancer Biol Ther· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis